Jai Lara Drugs Private Limited
Jai Lara Drugs Private Limited is a Private Indian company incorporated in 2010 and based in Telangana, India. Jai Lara Drugs Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Jai Lara Drugs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +1d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +7d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +26d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Jai Lara Drugs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 427260395 | ICICI Bank Ltd(Bank) | ₹24.36 Cr | 27 Jan 2020 | Open |
| 637289893 | Kotak Mahindra Bank Ltd(Bank) | ₹4.90 Cr | 27 Jan 2020 | Open |
| 582210123 | ICICI Bank Ltd(Bank) | ₹14.46 Cr | 12 Mar 2022 | Satisfied |
| 286309405 | ICICI Bank Ltd(Bank) | ₹6.41 Cr | 04 Jul 2021 | Open |
| 226462160 | HDFC Bank Ltd(Bank) | ₹12.73 Cr | 27 Jan 2020 | Open |
| 783284901 | Kotak Mahindra Bank Ltd(Bank) | ₹22.52 Cr | 27 Jan 2021 | Open |
Charge IDs, lenders & amounts for Jai Lara Drugs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹83.67 Cr | ₹-47.11 L | ₹31.26 Cr | ₹79.11 Cr | 325 |
| FY2023-24 | ₹72.45 Cr | ₹84.80 L | ₹62.48 Cr | ₹107.40 Cr | 85 |
| FY2022-23 | ₹58.56 Cr | ₹87.89 L | ₹37.29 Cr | ₹88.75 Cr | 45 |
| FY2021-22 | ₹61.41 Cr | ₹1.68 Cr | ₹33.57 Cr | ₹61.98 Cr | 288 |
Audited financials & ratios for Jai Lara Drugs Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹83.67 Cr | ₹72.45 Cr | ₹58.56 Cr | ₹61.41 Cr |
| Other income | ₹3.27 Cr | ₹38.31 L | ₹2.12 Cr | ₹1.83 Cr |
| Total income | ₹86.94 Cr | ₹72.83 Cr | ₹60.68 Cr | ₹63.24 Cr |
| Total expenses | ₹87.54 Cr | ₹71.74 Cr | ₹59.56 Cr | ₹61.09 Cr |
| Profit before tax | ₹-61.25 L | ₹1.10 Cr | ₹1.14 Cr | ₹2.18 Cr |
| Profit / (Loss) after tax | ₹-47.11 L | ₹84.80 L | ₹87.89 L | ₹1.68 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹31.26 Cr | ₹62.48 Cr | ₹37.29 Cr | ₹33.57 Cr |
| Borrowings | ₹11.59 Cr | ₹11.05 Cr | ₹25.68 Cr | ₹12.71 Cr |
| Current liabilities | ₹20.14 Cr | ₹19.23 Cr | ₹19.20 Cr | ₹14.55 Cr |
| Total liabilities | ₹47.85 Cr | ₹44.92 Cr | ₹51.47 Cr | ₹28.41 Cr |
| Current assets | ₹30.11 Cr | ₹43.63 Cr | ₹35.75 Cr | ₹31.35 Cr |
| Cash & equivalents | ₹8.17 Cr | ₹7.18 Cr | ₹6.41 Cr | ₹5.82 Cr |
| Total assets | ₹79.11 Cr | ₹107.40 Cr | ₹88.75 Cr | ₹61.98 Cr |
| Employees | 325 | 85 | 45 | 288 |
Audited financials & ratios for Jai Lara Drugs Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹83.67 Cr | +34.1% | +14.1% | -1.2% |
| Profit after Tax | ₹-47.11 L | +26.2% | +20.2% | +2.5% |
| Net Worth | ₹31.26 Cr | +9.0% | +11.6% | +3.1% |
| Employees | 325 | +17.2% | +4.4% | +11.4% |
Audited financials & ratios for Jai Lara Drugs Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹83.67 Cr | ₹-47.11 L | -0.56% | +23.07% | -1.51% | -0.60% | 0.37 | ₹25.74 L |
| FY2023-24 | ₹72.45 Cr | ₹84.80 L | +1.17% | -10.81% | +1.36% | +0.79% | 0.18 | ₹85.23 L |
| FY2022-23 | ₹58.56 Cr | ₹87.89 L | +1.50% | +1.05% | +2.36% | +0.99% | 0.69 | ₹1.30 Cr |
| FY2021-22 | ₹61.41 Cr | ₹1.68 Cr | +2.73% | +33.82% | +5.00% | +2.71% | 0.38 | ₹21.32 L |
Audited financials & ratios for Jai Lara Drugs Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,11,54,804 | 77.74% |
| Institutional Investors | 1 | 8,29,282 | 3.05% |
| Public & Others | 39 | 52,27,184 | 19.21% |
Promoter, institutional & public holding for Jai Lara Drugs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
138 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.